期刊文献+

慢性缺氧对大鼠血浆内皮素及心肌ETRa、CaM和CaMKII的影响

Impact of chronic hypoxia on plasma endothelin and ETRa,CaM,CaMKII in cardiac cells
下载PDF
导出
摘要 目的:研究慢性缺氧对大鼠血浆内皮素和心肌酶的影响。方法:以常压缺氧方式建立缺氧动物模型,SD幼鼠被随机分为3组:正常组、缺氧1周组和缺氧3周组,通过酶联免疫吸附试验检测不同组动物血浆内皮素变化,通过RT-PCR方法检测心肌组织中ETRa、CaM、CaMK II的mRNA表达。结果:血浆内皮素水平随缺氧时间延长而升高,正常组、缺氧1周组和缺氧3周组比较均有差异(P<0.05)。同时,心肌细胞ETRa、CaM、CaMK II mRNA的转录水平也随缺氧时间延长而增加,缺氧1周组和正常组比较有差异(P<0.05);但缺氧3周组和缺氧1周组比较有所不同,CaM和CaMK IIδ转录水平表现有差异(P<0.05),而ETRa和CaMK IIγ转录水平无差异(P>0.05)。结论:慢性缺氧使动物血浆中内皮素水平升高,心肌细胞ETRa、CaM和CaMK II mRNA转录增加,可能会对心脏功能产生影响。 AIM:To investigate the impact of chronic hypoxia on the changes of plasma endothelin concentration and myocardial enzymes in rats. METHODS:A hypoxia model was established on SD rats under normal air pressure with FiO2: 10%. The rats were randomly divided into three groups: the normal group, the group with 1 week, and the group with 3 week hypoxia. The levels of plasma endothelin were measured using ELISA method and the transcription of mRNA of ETRa, CaM and CaMKII were tested by RT-PCR. RESULTS : Hypoxia elevated the levels of plasma endothelin in a time-dependent manner with significant differences among three groups (P 〈 0.05). The transcriptions of mRNA of ETRa, CaM, and CaMKII were also significantly upregulated in 1 week group ( P 〈 0.05 ) and 3 week group. Between the two groups ; the transcription of mRNA of CaM and CaMKⅡδ were significant different (P 〈 0.05 ) , while ETRa and CaMKⅡγ were unchanged (P 〉 0.05 ). CONCLUSION: The hypoxia induced elevation of plasma endothelin and upregulation of the transcription of mRNA of ETRa, CaM and CaMKII may exert some impacts on cardiac functions.
出处 《心脏杂志》 CAS 2005年第6期514-516,共3页 Chinese Heart Journal
关键词 慢性缺氧 内皮素 钙调素 钙/钙调素依赖性蛋白激酶Ⅱ chronic hypoxia endothelin calmodulin CaMKⅡ
  • 相关文献

参考文献10

  • 1Milano G, Corno AF, Lippa S, et al. Chronic and intermittent hypoxia induce different degrees of myocardial tolerance to hypoxia-induced dysfunction [ J ]. Exp Biol Med, 2002,227(6):389-397.
  • 2Ostadal B, Ostadalova I, Dhalla NS. Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects [ J ].Physiol Rev, 1999, 79(3):635 - 659.
  • 3Baker JE, Hohnan P, Kalyanaraman B, et al. Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production [J]. Ann N Y Acad Sci, 1999,874:236 - 253.
  • 4张小勇,光雪峰.内皮素与充血性心力衰竭[J].心脏杂志,2003,15(3):262-264. 被引量:1
  • 5Giaid A. Nitric oxide and endothelin-1 in puhnonaty hypertension[J]. Chest,1998,114: 208S - 212S.
  • 6Zhu WD, Zou YZ, Shiojima I, et al. Ca^2+ cahnoduhn-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy [ J ]. J Biol Chem, 2000, 275( 20 ):15239 - 15245.
  • 7Delgado C, Artiles A, Gomez AM, et al. Frequency-dependent increase in cardiac Ca^2+ current is clue to reduced Ca^2+ release by the sarcoplasmic reticulum[J]. J Mol Cell Cardiol, 1999,31(10):1783-1793.
  • 8Huhne JT, Orchard CH. Effect of acidosis on Ca^2+ uptake and release by sarcoplasmic reticulum of intact rat ventricular myocytes[ J ]. Am J Pbysiol, 1998,275(3 Pt 2): H977 - H978.
  • 9Sica AL, Greenberg HE, Ruggiero DA, et al. Chronic - intermittent hypoxia: a model of sympathetic activation in the rat[J]. Res Physiol, 2000,121: 173 - 184.
  • 10Prabhakar NR, Fields RD, Baker T, et al. Intermittent hypoxia: cell to system[J]. Am J Physiol Lung Cell Mol Physiol,2001,281: L524-L528.

二级参考文献13

  • 1Verhaar MC, Strachan FE, Newby DE, et al. Endothelin-A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade[J]. Circulation, 1998,97(8):752--756.
  • 2Ponicke K, Vogelsang M, Heiroth M, et al. Endothelin receptors in the failing and nonfailing heart[J]. Circulation, 1998,97:744--751.
  • 3MacCarthy PY, Grocott-Mason R, Prendergast BD, et al. Contrasting inotropic effects of endogeneous endothelin in the normal and failing human heart[J]. Circulation, 2000, 101:142--147.
  • 4Kobayshi T, Miysuchi T, Sakai S, et al. Downregulation of ET(B)receptor, but not ET(A) receptor, in congetive lung secondary to heart failure. Are marked increase in circulating endothelin-1 partly attributable to decrease in lung ET(B) receptor-mediated clearance of endothelin-1?[J]. Life Sci,1998,62:185--193.
  • 5Donckier JE. Therapeutic role of bosentan in hypertension, lesions from the model of perinephritic hypertension[J]. Heart Fail Rev, 2001,6 :253-- 264.
  • 6Pernow J, Wang QD. Endothelin in myocardial ischemia and reperfusion[J]. Cardiovasc Res, 1997,33: 518.
  • 7Spiekar LE, Mitrovic V, Noll G, et al. Acute hemodynamic and neurohumoral effects ofselective ETA-receptor blockade in patients with congestive heart failure [J]. J Am Coll Cardiol,2000,35: 1745--1752.
  • 8Zolk O, Quattek J, Sitzler G, et al. Expression of endothelin-- 1, endothelin-converting enzyme, and endothlin receptors in chronic heart failure[J]. Circulation,1999,99:2118--2123.
  • 9Packer M, Caspi A, Charlon V, et al. Multicenter, doubleblind, placebo-controlled study of long-term endothelin blockade with bosentan in chronic heart failure-results of the REACH-1 trial[J]. Circulation, 1998,98 (Supp1) : S12.
  • 10Torre-Amione G, Young JB, Durand JB,et al. Hemodynamic effecta of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class Ⅱ to IV congestive heart failure[J]. Circulation, 2001,103 : 973- 980.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部